Autophagy regulators as potential cancer therapeutic agents: A review

Current Topics in Medicinal Chemistry

Volumn 15, Issue 8, 2015, Pages 720-744

  Li, Shan ^a   Wang, Lingfei ^a   Hu, Yongzhou ^a   Sheng, Rong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Autolysosome; Autophagy; Autophagy inducers; Autophagy inhibitors; Beclin1; Cancer treatment; Drug discovery

Indexed keywords

2 (4 AMINO 1 ISOPROPYL 1H PYRAZOLO [3, 4 D] PYRIMIDIN 3 YL) 1H INDOL 5 OL; 4 (4 AMINO 5 (7 METHOXY 1H INDOL 2 YL) IMIDAZO [5, 1 F] [1, 2, 4] TRIAZIN 7 YL) CYCLOHEXANECARBOXYLIC ACID; ANTINEOPLASTIC AGENT; AZD 8055; BECLIN 1; CHLOROQUINE; CYCLOHEXIMIDE; CYCLOVIROBUXINE D; DIHYDROARTEMISININ; ERLOTINIB; GEFITINIB; GERANIOL; HESPERIDIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NILOTINIB; OXALIPLATIN; PARTHENOLIDE; PAZOPANIB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SORAFENIB; SUNITINIB; TEMSIROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER GROWTH; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL (TOPIC); CYTOTOXICITY; DNA DAMAGE; DRUG EFFICACY; DRUG STRUCTURE; DRUG TARGETING; HOMEOSTASIS; HUMAN; METABOLIC STRESS; NEOPLASM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; DRUG DEVELOPMENT; DRUG EFFECTS; NEOPLASMS;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; DRUG DISCOVERY; HUMANS; NEOPLASMS;

EID: 84930918988     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150302105343     Document Type: Article

References (227)

1. Rubinsztein, D. C.; Codogno, P.; Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov., 2012, 11 (9), 709-730.
2. Morselli, E.; Galluzzi, L.; Kepp, O.; Marino, G.; Michaud, M.; Vitale, I.; Maiuri, M. C.; Kroemer, G. Oncosuppressive functions of autophagy. Antioxid. Redox Signal., 2011, 14 (11), 2251-2269.
3. Green, D. R.; Levine, B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell, 2014, 157 (1), 65-75.
4. Loos, B.; Engelbrecht, A. M.; Lockshin, R. A.; Klionsky, D. J.; Zakeri, Z. The variability of autophagy and cell death susceptibility: Unanswered questions. Autophagy, 2013, 9 (9), 1270-1285.
5. Janku, F.; McConkey, D. J.; Hong, D. S.; Kurzrock, R. Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol., 2011, 8 (9), 528-539.
6. Dice, J. F. Chaperone-mediated autophagy. Autophagy, 2007, 3 (4), 295-299.
7. Kaushik, S.; Cuervo, A. M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol., 2012, 22 (8), 407-417.
8. Chen, Y.; Klionsky, D. J. The regulation of autophagy-unanswered questions. J. Cell Sci., 2011, 124 (Pt 2), 161-170.
9. Mijaljica, D.; Prescott, M.; Devenish, R. J. Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy, 2011, 7 (7), 673-682.
10. Ghavami, S.; Shojaei, S.; Yeganeh, B.; Ande, S. R.; Jangamreddy, J. R.; Mehrpour, M.; Christoffersson, J.; Chaabane, W.; Moghadam, A. R.; Kashani, H. H.; Hashemi, M.; Owji, A. A.; Los, M. J. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol., 2014, 112, 24-49.
11. Wang, X. J.; Yu, J.; Wong, S. H.; Cheng, A. S. L.; Chan, F. K. L.; Ng, S. S. M.; Cho, C. H.; Sung, J. J. Y.; Wu, W. K. K. A novel crosstalk between two major protein degradation systems Regulation of proteasomal activity by autophagy. Autophagy, 2013, 9 (10), 1500-1508.
12. Awan, M. U.; Deng, Y. Role of autophagy and its significance in cellular homeostasis. Appl. Microbiol. Biotechnol., 2014, 98 (12), 5319-5328.
13. Zaglia, T.; Milan, G.; Ruhs, A.; Franzoso, M.; Bertaggia, E.; Pianca, N.; Carpi, A.; Carullo, P.; Pesce, P.; Sacerdoti, D.; Sarais, C.; Catalucci, D.; Kruger, M.; Mongillo, M.; Sandri, M. Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. J. Clin. Invest., 2014, 124 (6), 2410-2424.
14. Wu, L.; Yan, B. Discovery of small molecules that target autophagy for cancer treatment. Curr. Med. Chem., 2011, 18 (12), 1866-1873.
15. Yang, L.; Li, P.; Fu, S.; Calay, E. S.; Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab., 2010, 11 (6), 467-478.
16. Singh, R.; Kaushik, S.; Wang, Y.; Xiang, Y.; Novak, I.; Komatsu, M.; Tanaka, K.; Cuervo, A. M.; Czaja, M. J. Autophagy regulates lipid metabolism. Nature, 2009, 458 (7242), 1131-1135.
17. Spencer, B.; Potkar, R.; Trejo, M.; Rockenstein, E.; Patrick, C.; Gindi, R.; Adame, A.; Wyss-Coray, T.; Masliah, E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci., 2009, 29 (43), 13578-13588.
18. Menzies, F. M.; Huebener, J.; Renna, M.; Bonin, M.; Riess, O.; Rubinsztein, D. C. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain, 2010, 133 (Pt 1), 93-104.
19. Rubinsztein, D. C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature, 2006, 443 (7113), 780-786.
20. Levine, B.; Mizushima, N.; Virgin, H. W. Autophagy in immunity and inflammation. Nature, 2011, 469 (7330), 323-335.
21. Virgin, H. W.; Levine, B. Autophagy genes in immunity. Nat. Immunol., 2009, 10 (5), 461-470.
22. Mathew, R.; Karantza-Wadsworth, V.; White, E. Role of autophagy in cancer. Nat. Rev. Cancer, 2007, 7 (12), 961-967.
23. Turcotte, S.; Giaccia, A. J. Targeting cancer cells through autophagy for anticancer therapy. Curr. Opin. Cell Biol., 2010, 22 (2), 246-251.
24. Giuliani, C. M.; Dass, C. R. Metabolic stress and cancer: is autophagy the common denominator and a feasible target? J. Pharm. Pharmacol., 2014, 66 (5), 597-614.
25. Amaravadi, R. K.; Lippincott-Schwartz, J.; Yin, X. M.; Weiss, W. A.; Takebe, N.; Timmer, W.; DiPaola, R. S.; Lotze, M. T.; White, E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res., 2011, 17 (4), 654-666.
26. Rubinsztein, D. C.; Shpilka, T.; Elazar, Z. Mechanisms of autophagosome biogenesis. Curr. Biol., 2012, 22 (1), R29-34.
27. Hayashi-Nishino, M.; Fujita, N.; Noda, T.; Yamaguchi, A.; Yoshimori, T.; Yamamoto, A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol., 2009, 11 (12), 1433-1437.
28. Ravikumar, B.; Moreau, K.; Jahreiss, L.; Puri, C.; Rubinsztein, D. C. Plasma membrane contributes to the formation of preautophagosomal structures. Nat. Cell Biol., 2010, 12 (8), 747-757.
29. Nishida, Y.; Arakawa, S.; Fujitani, K.; Yamaguchi, H.; Mizuta, T.; Kanaseki, T.; Komatsu, M.; Otsu, K.; Tsujimoto, Y.; Shimizu, S. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature, 2009, 461 (7264), 654-658.
30. Hailey, D. W.; Rambold, A. S.; Satpute-Krishnan, P.; Mitra, K.; Sougrat, R.; Kim, P. K.; Lippincott-Schwartz, J. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell, 2010, 141 (4), 656-667.
31. Rubinsztein, D. C.; Gestwicki, J. E.; Murphy, L. O.; Klionsky, D. J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov., 2007, 6 (4), 304-312.
32. Yue, Z. Y.; Jin, S. K.; Yang, C. W.; Levine, A. J.; Heintz, N. Beclin 1, an autophagy gene essential for early embryonic develop ment, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA, 2003, 100 (25), 15077-15082.
33. Yan, Y.; Backer, J. M. Regulation of class III (Vps34) PI3Ks. Biochem. Soc. Trans., 2007, 35 (Pt 2), 239-241.
34. Backer, J. M. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J., 2008, 410 (1), 1-17.
35. Pattingre, S.; Espert, L.; Biard-Piechaczyk, M.; Codogno, P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie, 2008, 90 (2), 313-323.
36. Nakatogawa, H.; Ichimura, Y.; Ohsumi, Y. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell, 2007, 130 (1), 165-178.
37. Saftig, P.; Beertsen, W.; Eskelinen, E. L. LAMP-2-A control step for phagosome and autophagosome maturation. Autophagy, 2008, 4 (4), 510-512.
38. Klionsky, D. J.; Elazar, Z.; Seglen, P. O.; Rubinsztein, D. C. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy, 2008, 4 (7), 849-850.
39. Kuma, A.; Matsui, M.; Mizushima, N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy, 2007, 3 (4), 323-328.
40. Pattingre, S.; Espert, L.; Biard-Piechaczyk, M.; Codogno, P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie, 2008, 90 (2), 313-323.
41. Wu, S.; Chu, Y.; Yang, Y.; Li, Y.; He, P.; Zheng, Y.; Zhang, C.; Liu, Q.; Han, L.; Huang, R. Inhibition of macrophage autophagy induced by Salmonella enterica serovar typhi plasmid. Front Biosci (Landmark Ed), 2014, 19, 490-503.
42. Kondo, Y.; Kanzawa, T.; Sawaya, R.; Kondo, S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer, 2005, 5 (9), 726-734.
43. Yu, L.; McPhee, C. K.; Zheng, L.; Mardones, G. A.; Rong, Y.; Peng, J.; Mi, N.; Zhao, Y.; Liu, Z.; Wan, F.; Hailey, D. W.; Oorschot, V.; Klumperman, J.; Baehrecke, E. H.; Lenardo, M. J. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature, 2010, 465 (7300), 942-946.
44. Behrends, C.; Sowa, M. E.; Gygi, S. P.; Harper, J. W. Network organization of the human autophagy system. Nature, 2010, 466 (7302), 68-76.
45. Yang, Z. J.; Chee, C. E.; Huang, S.; Sinicrope, F. A. The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther., 2011, 10 (9), 1533-1541.
46. Chan, E. Y. mTORC1 Phosphorylates the ULK1-mAtg13-FIP200 Autophagy Regulatory Complex. Sci. Signal., 2009, 2 (84).
47. Egan, D. F.; Shackelford, D. B.; Mihaylova, M. M.; Gelino, S.; Kohnz, R. A.; Mair, W.; Vasquez, D. S.; Joshi, A.; Gwinn, D. M.; Taylor, R.; Asara, J. M.; Fitzpatrick, J.; Dillin, A.; Viollet, B.; Kundu, M.; Hansen, M.; Shaw, R. J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science, 2011, 331 (6016), 456-461.
48. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X. H.; Mizushima, N.; Packer, M.; Schneider, M. D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell, 2005, 122 (6), 927-939.
49. Bellot, G.; Garcia-Medina, R.; Gounon, P.; Chiche, J.; Roux, D.; Pouyssegur, J.; Mazure, N. M. Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains. Mol. Cell. Biol., 2009, 29 (10), 2570-2581.
50. Azad, M. B.; Chen, Y. Q.; Gibson, S. B. Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment. Antioxid. Redox Signal., 2009, 11 (4), 777-790.
51. Chen, Y.; McMillan-Ward, E.; Kong, J.; Israels, S. J.; Gibson, S. B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci., 2007, 120 (Pt 23), 4155-4166.
52. Gibson, S. B. A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy, 2010, 6 (7), 835-837.
53. Li, Z. Y.; Yang, Y.; Ming, M.; Liu, B. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun., 2011, 414 (1), 5-8.
54. Scherz-Shouval, R.; Shvets, E.; Elazar, Z. Oxidation as a posttranslational modification that regulates autophagy. Autophagy, 2007, 3 (4), 371-373.
55. Meley, D.; Bauvy, C.; Houben-Weerts, J. H.; Dubbelhuis, P. F.; Helmond, M. T.; Codogno, P.; Meijer, A. J. AMP-activated protein kinase and the regulation of autophagic proteolysis. J. Biol. Chem., 2006, 281 (46), 34870-34879.
56. Maycotte, P.; Thorburn, A. Autophagy and cancer therapy. Cancer Biol. Ther., 2011, 11 (2), 127-137.
57. Abedin, M. J.; Wang, D.; McDonnell, M. A.; Lehmann, U.; Kelekar, A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ., 2007, 14 (3), 500-510.
58. Zhong, Y.; Wang, Q. J.; Li, X.; Yan, Y.; Backer, J. M.; Chait, B. T.; Heintz, N.; Yue, Z. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat. Cell Biol., 2009, 11 (4), 468-476.
59. Liang, X. H.; Jackson, S.; Seaman, M.; Brown, K.; Kempkes, B.; Hibshoosh, H.; Levine, B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999, 402 (6762), 672-676.
60. Qu, X.; Yu, J.; Bhagat, G.; Furuya, N.; Hibshoosh, H.; Troxel, A.; Rosen, J.; Eskelinen, E. L.; Mizushima, N.; Ohsumi, Y.; Cattoretti, G.; Levine, B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest., 2003, 112 (12), 1809-1820.
61. Degenhardt, K.; Mathew, R.; Beaudoin, B.; Bray, K.; Anderson, D.; Chen, G.; Mukherjee, C.; Shi, Y.; Gelinas, C.; Fan, Y.; Nelson, D. A.; Jin, S.; White, E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 2006, 10 (1), 51-64.
62. He, C.; Levine, B. The Beclin 1 interactome. Curr. Opin. Cell Biol., 2010, 22 (2), 140-149.
63. Denton, D.; Nicolson, S.; Kumar, S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ., 2012, 19 (1), 87-95.
64. Maiuri, M. C.; Zalckvar, E.; Kimchi, A.; Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol., 2007, 8 (9), 741-752.
65. Yang, S.; Wang, X.; Contino, G.; Liesa, M.; Sahin, E.; Ying, H.; Bause, A.; Li, Y.; Stommel, J. M.; Dell'antonio, G.; Mautner, J.; Tonon, G.; Haigis, M.; Shirihai, O. S.; Doglioni, C.; Bardeesy, N.; Kimmelman, A. C. Pancreatic cancers require autophagy for tumor growth. Genes Dev., 2011, 25 (7), 717-729.
66. Lisanti, M. P.; Martinez-Outschoorn, U. E.; Chiavarina, B.; Pavlides, S.; Whitaker-Menezes, D.; Tsirigos, A.; Witkiewicz, A.; Lin, Z.; Balliet, R.; Howell, A.; Sotgia, F. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor microenvironment. Cancer Biol. Ther., 2010, 10 (6), 537-542.
67. Lu, S. Z.; Harrison-Findik, D. D. Autophagy and cancer. World J. Biol. Chem., 2013, 4 (3), 64-70.
68. Kimmelman, A. C. The dynamic nature of autophagy in cancer. Genes Dev., 2011, 25 (19), 1999-2010.
69. Lum, J. J.; Bauer, D. E.; Kong, M.; Harris, M. H.; Li, C.; Lindsten, T.; Thompson, C. B. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 2005, 120 (2), 237-248.
70. Gewirtz, D. A. The four faces of autophagy: implications for cancer therapy. Cancer Res., 2014, 74 (3), 647-651.
71. Gewirtz, D. A. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy, 2013, 9 (9), 1263-1265.
72. Wu, W. K.; Coffelt, S. B.; Cho, C. H.; Wang, X. J.; Lee, C. W.; Chan, F. K.; Yu, J.; Sung, J. J. The autophagic paradox in cancer therapy. Oncogene, 2012, 31 (8), 939-953.
73. Gibson, S. B. A matter of balance between life and death Targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy, 2010, 6 (7), 835-837.
74. Liu, W.; Huang, S.; Chen, Z.; Wang, H.; Wu, H.; Zhang, D. Temsirolimus, the mTOR inhibitor, induces autophagy in adenoid cystic carcinoma: In vitro and in vivo. Pathol. Res. Pract., 2014.
75. Thoreen, C. C.; Kang, S. A.; Chang, J. W.; Liu, Q.; Zhang, J.; Gao, Y.; Reichling, L. J.; Sim, T.; Sabatini, D. M.; Gray, N. S. An ATPcompetitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem., 2009, 284 (12), 8023-8032.
76. Li, J. R.; Cheng, C. L.; Yang, C. R.; Ou, Y. C.; Wu, M. J.; Ko, J. L. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Toxicol. Lett., 2013, 220 (3), 267-276.
77. Dong, L. H.; Cheng, S.; Zheng, Z.; Wang, L.; Shen, Y.; Shen, Z. X.; Chen, S. J.; Zhao, W. L. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. J. Hematol. Oncol., 2013, 6.
78. Bhagwat, S. V.; Gokhale, P. C.; Crew, A. P.; Cooke, A.; Yao, Y.; Mantis, C.; Kahler, J.; Workman, J.; Bittner, M.; Dudkin, L.; Epstein, D. M.; Gibson, N. W.; Wild, R.; Arnold, L. D.; Houghton, P. J.; Pachter, J. A. Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin. Mol. Cancer Ther., 2011, 10 (8), 1394-1406.
79. Altman, J. K.; Sassano, A.; Kaur, S.; Glaser, H.; Kroczynska, B.; Redig, A. J.; Russo, S.; Barr, S.; Platanias, L. C. Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors. Clin. Cancer Res., 2011, 17 (13), 4378-4388.
80. Chresta, C. M.; Davies, B. R.; Hickson, I.; Harding, T.; Cosulich, S.; Critchlow, S. E.; Vincent, J. P.; Ellston, R.; Jones, D.; Sini, P.; James, D.; Howard, Z.; Dudley, P.; Hughes, G.; Smith, L.; Maguire, S.; Hummersone, M.; Malagu, K.; Menear, K.; Jenkins, R.; Jacobsen, M.; Smith, G. C. M.; Guichard, S.; Pass, M. AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity. Cancer Res., 2010, 70 (1), 288-298.
81. Hu, M.; Huang, H. L.; Zhao, R.; Li, P.; Li, M. Y.; Miao, H. L.; Chen, N. P.; Chen, M. AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma. Oncol. Rep., 2014, 31 (2), 649-656.
82. Gini, B.; Zanca, C.; Guo, D. L.; Matsutani, T.; Masui, K.; Ikegami, S.; Yang, H. J.; Nathanson, D.; Villa, G. R.; Shackelford, D.; Zhu, S. J.; Tanaka, K.; Babic, I.; Akhavan, D.; Lin, K.; Assuncao, A.; Gu, Y. C.; Bonetti, B.; Mortensen, D. S.; Xu, S. C.; Raymon, H. K.; Cavenee, W. K.; Furnari, F. B.; James, C. D.; Kroemer, G.; Heath, J. R.; Hege, K.; Chopra, R.; Cloughesy, T. F.; Mischel, P. S. The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas. Clin. Cancer Res., 2013, 19 (20), 5722-5732.
83. Mortensen, D. S.; Sapienza, J.; Lee, B. G. S.; Perrin-Ninkovic, S. M.; Harris, R.; Shevlin, G.; Parnes, J. S.; Whitefield, B.; Hickman, M.; Khambatta, G.; Bisonette, R. R.; Peng, S.; Gamez, J. C.; Leisten, J.; Narla, R. K.; Fultz, K. E.; Sankar, S. Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase. Bioorg. Med. Chem. Lett., 2013, 23 (6), 1588-1591.
84. Liu, Q.; Wang, J.; Kang, S. A.; Thoreen, C. C.; Hur, W.; Ahmed, T.; Sabatini, D. M.; Gray, N. S. Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1, 6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. J. Med. Chem., 2011, 54 (5), 1473-1480.
85. Liu, Q.; Xu, C.; Kirubakaran, S.; Zhang, X.; Hur, W.; Liu, Y.; Kwiatkowski, N. P.; Wang, J.; Westover, K. D.; Gao, P.; Ercan, D.; Niepel, M.; Thoreen, C. C.; Kang, S. A.; Patricelli, M. P.; Wang, Y.; Tupper, T.; Altabef, A.; Kawamura, H.; Held, K. D.; Chou, D. M.; Elledge, S. J.; Janne, P. A.; Wong, K. K.; Sabatini, D. M.; Gray, N. S. Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. Cancer Res., 2013, 73 (8), 2574-2586.
86. Zhou, J.; Tan, S. H.; Nicolas, V.; Bauvy, C.; Yang, N. D.; Zhang, J.; Xue, Y.; Codogno, P.; Shen, H. M. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Cell Res., 2013, 23 (4), 508-523.
87. Liu, T. J.; Koul, D.; LaFortune, T.; Tiao, N.; Shen, R. J.; Maira, S. M.; Garcia-Echevrria, C.; Yung, W. K. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol. Cancer Ther., 2009, 8 (8), 2204-2210.
88. Kuger, S.; Corek, E.; Polat, B.; Kammerer, U.; Flentje, M.; Djuzenova, C. S. Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions. Breast Cancer (Auckl), 2014, 8, 39-49.
89. Fan, Q. W.; Knight, Z. A.; Goldenberg, D. D.; Yu, W.; Mostov, K. E.; Stokoe, D.; Shokat, K. M.; Weiss, W. A. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell, 2006, 9 (5), 341-349.
90. Aronson, L. I.; Davenport, E. L.; Mirabella, F.; Morgan, G. J.; Davies, F. E. Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application. Leukemia, 2013, 27 (12), 2397-2403.
91. Han, W.; Pan, H.; Chen, Y.; Sun, J.; Wang, Y.; Li, J.; Ge, W.; Feng, L.; Lin, X.; Wang, X.; Wang, X.; Jin, H. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS ONE, 2011, 6 (6), e18691.
92. Yu, H. C.; Lin, C. S.; Tai, W. T.; Liu, C. Y.; Shiau, C. W.; Chen, K. F. Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation. J. Biol. Chem., 2013, 288 (25), 18249-18259.
93. Santoni, M.; Amantini, C.; Morelli, M. B.; Liberati, S.; Farfariello, V.; Nabissi, M.; Bonfili, L.; Eleuteri, A. M.; Mozzicafreddo, M.; Burattini, L.; Berardi, R.; Cascinu, S.; Santoni, G. Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. Br. J. Cancer, 2013, 109 (4), 1040-1050.
94. Lin, J. C.; Huang, W. P.; Liu, C. L.; Lee, J. J.; Liu, T. P.; Ko, W. C.; Huang, Y. C.; Hsu, M. L.; Wu, C. H.; Chen, Y. J. Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts. Transplantation, 2013, 95 (6), 791-800.
95. Feng, X.; Li, L.; Jiang, H.; Jiang, K.; Jin, Y.; Zheng, J. Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy. Biochem. Biophys. Res. Commun., 2014, 444 (3), 376-381.
96. Yuan, G.; Yan, S. F.; Xue, H.; Zhang, P.; Sun, J. T.; Li, G. Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivo. J. Biol. Chem., 2014, 289 (15), 10607-10619.
97. Zhan, Y. H.; Liu, J.; Qu, X. J.; Hou, K. Z.; Wang, K. F.; Liu, Y. P.; Wu, B. beta-Elemene Induces Apoptosis in Human Renal-cell Carcinoma 786-0 Cells through Inhibition of MAPK/ERK and PI3K/Akt/mTOR Signalling Pathways. Asian Pac. J. Cancer Prev., 2012, 13 (6), 2739-2744.
98. Liu, J.; Hu, X. J.; Jin, B.; Qu, X. J.; Hou, K. Z.; Liu, Y. P. ss-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J. Pharm. Pharmacol., 2012, 64 (1), 146-153.
99. Kim, S. H.; Park, E. J.; Lee, C. R.; Chun, J. N.; Cho, N. H.; Kim, I. G.; Lee, S.; Kim, T. W.; Park, H. H.; So, I.; Jeon, J. H. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int. J. Oncol., 2012, 40 (5), 1683-1690.
100. Suh, Y.; Afaq, F.; Khan, N.; Johnson, J. J.; Khusro, F. H.; Mukhtar, H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis, 2010, 31 (8), 1424-1433.
101. Xia, J.; Guo, S.; Fang, T.; Feng, D.; Zhang, X.; Zhang, Q.; Liu, J.; Liu, B.; Li, M.; Zhu, R. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem. Toxicol., 2014, 66, 7-13.
102. Lee, Y.; Sung, B.; Kang, Y. J.; Kim, D. H.; Jang, J. Y.; Hwang, S. Y.; Kim, M.; Lim, H. S.; Yoon, J. H.; Chung, H. Y.; Kim, N. D. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. Int. J. Oncol., 2014, 44 (5), 1599-1606.
103. Saiprasad, G.; Chitra, P.; Manikandan, R.; Sudhandiran, G. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis. Eur. J. Cancer, 2014.
104. Zhang, X.; Wei, H.; Liu, Z.; Yuan, Q.; Wei, A.; Shi, D.; Yang, X.; Ruan, J. A novel protoapigenone analog RY10-4 induces breast cancer MCF-7 cell death through autophagy via the Akt/mTOR pathway. Toxicol. Appl. Pharmacol., 2013, 270 (2), 122-128.
105. Jiang, H.; Sun, J.; Xu, Q.; Liu, Y.; Wei, J.; Young, C. Y.; Yuan, H.; Lou, H. Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells. Cell Death Dis., 2013, 4, e761.
106. Poornima, P.; Weng, C. F.; Padma, V. V. Neferine from Nelumbo nucifera induces autophagy through the inhibition of PI3K/Akt/mTOR pathway and ROS hyper generation in A549 cells. Food Chem., 2013, 141 (4), 3598-3605.
107. Hung, J. Y.; Hsu, Y. L.; Li, C. T.; Ko, Y. C.; Ni, W. C.; Huang, M. S.; Kuo, P. L. 6-Shogaol, an Active Constituent of Dietary Ginger, Induces Autophagy by Inhibiting the AKT/mTOR Pathway in Human Non-Small Cell Lung Cancer A549 Cells. J. Agric. Food Chem., 2009, 57 (20), 9809-9816.
108. Li, H. B.; Yi, X.; Gao, J. M.; Ying, X. X.; Guan, H. Q.; Li, J. C. Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch. Pharm. Res., 2007, 30 (12), 1566-1574.
109. Wu, J. C.; Lai, C. S.; Badmaev, V.; Nagabhushanam, K.; Ho, C. T.; Pan, M. H. Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol. Nutr. Food Res., 2011, 55 (11), 1646-1654.
110. Kumar, D.; Shankar, S.; Srivastava, R. K. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett., 2014, 343 (2), 179-189.
111. Singh, B. N.; Kumar, D.; Shankar, S.; Srivastava, R. K. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem. Pharmacol., 2012, 84 (9), 1154-1163.
112. Ge, J.; Liu, Y.; Li, Q.; Guo, X.; Gu, L.; Ma, Z. G.; Zhu, Y. P. Resveratrol Induces Apoptosis and Autophagy in T-cell Acute Lymphoblastic Leukemia Cells by Inhibiting Akt/mTOR and Activating p38-MAPK. Biomed. Environ. Sci., 2013, 26 (11), 902-911.
113. Wang, M.; Yu, T.; Zhu, C. Y.; Sun, H.; Qiu, Y.; Zhu, X.; Li, J. C. Resveratrol Triggers Protective Autophagy Through the Ceramide/Akt/mTOR Pathway in Melanoma B16 Cells. Nutr. Cancer Int. J., 2014, 66 (3), 435-440.
114. Opipari, A. W., Jr.; Tan, L.; Boitano, A. E.; Sorenson, D. R.; Aurora, A.; Liu, J. R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res., 2004, 64 (2), 696-703.
115. Chu, Y. L.; Ho, C. T.; Chung, J. G.; Raghu, R.; Lo, Y. C.; Sheen, L. Y. Allicin Induces Anti-human Liver Cancer Cells through the p53 Gene Modulating Apoptosis and Autophagy. J. Agric. Food Chem., 2013, 61 (41), 9839-9848.
116. Chu, Y. L.; Ho, C. T.; Chung, J. G.; Rajasekaran, R.; Sheen, L. Y. Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. J. Agric. Food Chem., 2012, 60 (34), 8363-8371.
117. Jing, K.; Song, K. S.; Shin, S.; Kim, N.; Jeong, S.; Oh, H. R.; Park, J. H.; Seo, K. S.; Heo, J. Y.; Han, J.; Park, J. I.; Han, C.; Wu, T.; Kweon, G. R.; Park, S. K.; Yoon, W. H.; Hwang, B. D.; Lim, K. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy, 2011, 7 (11), 1348-1358.
118. Yun, S. M.; Jung, J. H.; Jeong, S. J.; Sohn, E. J.; Kim, B.; Kim, S. H. Tanshinone IIA Induces Autophagic Cell Death via Activation of AMPK and ERK and Inhibition of mTOR and p70 S6K in KBM-5 Leukemia Cells. Phytother. Res., 2014, 28 (3), 458-464.
119. Li, Y. C.; He, S. M.; He, Z. X.; Li, M. H.; Yang, Y. X.; Pang, J. X.; Zhang, X. J.; Chow, K. V.; Zhou, Q. Y.; Duan, W.; Zhou, Z. W.; Yang, T. X.; Huang, G. H.; Liu, A. B.; Qiu, J. X.; Liu, J. P.; Zhou, S. F. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human nonsmall cell lung cancer cells. Cancer Lett., 2014, 344 (2), 239-259.
120. Papageorgiou, V. P.; Assimopoulou, A. N.; Couladouros, E. A.; Hepworth, D.; Nicolaou, K. C. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angewandte Chemie-International Edition, 1999, 38 (3), 270-301.
121. Acharya, B. R.; Bhattacharyya, S.; Choudhury, D.; Chakrabarti, G. The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis, 2011, 16 (9), 924-939.
122. Kumar, V. B.; Yuan, T. C.; Liou, J. W.; Yang, C. J.; Sung, P. J.; Weng, C. F. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles. Mutation Research-Fundamental And Molecular Mechanisms Of Mutagenesis, 2011, 707 (1-2), 42-52.
123. Yu, C. C.; Chiang, P. C.; Lu, P. H.; Kuo, M. T.; Wen, W. C.; Chen, P. N.; Guh, J. H. Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells. J. Nutr. Biochem., 2012, 23 (8), 900-907.
124. Saiki, S.; Sasazawa, Y.; Imamichi, Y.; Kawajiri, S.; Fujimaki, T.; Tanida, I.; Kobayashi, H.; Sato, F.; Sato, S.; Ishikawa, K. I.; Imoto, M.; Hattori, N. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy, 2011, 7 (2), 176-187.
125. Fokas, E.; Yoshimura, M.; Prevo, R.; Higgins, G.; Hackl, W.; Maira, S. M.; Bernhard, E. J.; McKenna, W. G.; Muschel, R. J. NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity. Radiat. Oncol., 2012, 7.
126. Wang, W. J.; Long, L. M.; Yang, N.; Zhang, Q. Q.; Ji, W. J.; Zhao, J. H.; Qin, Z. H.; Wang, Z.; Chen, G.; Liang, Z. Q. NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro. Acta Pharmacol. Sin., 2013, 34 (5), 681-690.
127. Martin, A. P.; Park, M. A.; Mitchell, C.; Walker, T.; Rahmani, M.; Thorburn, A.; Haussinger, D.; Reinehr, R.; Grant, S.; Dent, P. BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing. Mol. Pharmacol., 2009, 76 (2), 327-341.
128. Zhang, D. M.; Liu, J. S.; Deng, L. J.; Chen, M. F.; Yiu, A.; Cao, H. H.; Tian, H. Y.; Fung, K. P.; Kurihara, H.; Pan, J. X.; Ye, W. C. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis, 2013, 34 (6), 1331-1342.
129. Lu, J.; Sun, D. P.; Gao, S.; Gao, Y.; Ye, J. T.; Liu, P. Q. Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells. J. Pharmacol. Sci., 2014, 125 (1), 74-82.
130. Wang, W. K.; Lin, S. T.; Chang, W. W.; Liu, L. W.; Li, T. Y.; Kuo, C. Y.; Hsieh, J. L.; Lee, C. H. Hinokitiol induces autophagy in murine breast and colorectal cancer cells. Environ. Toxicol., 2014.
131. Luciani, A.; Villella, V. R.; Esposito, S.; Brunetti-Pierri, N.; Medina, D.; Settembre, C.; Gavina, M.; Pulze, L.; Giardino, I.; Pettoello-Mantovani, M.; D'Apolito, M.; Guido, S.; Masliah, E.; Spencer, B.; Quaratino, S.; Raia, V.; Ballabio, A.; Maiuri, L. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat. Cell Biol., 2010, 12 (9), 863-875.
132. Guo, W.; Zhao, Y.; Zhang, Z.; Tan, N.; Zhao, F.; Ge, C.; Liang, L.; Jia, D.; Chen, T.; Yao, M.; Li, J.; He, X. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett., 2011, 312 (1), 55-61.
133. Dando, I.; Fiorini, C.; Pozza, E. D.; Padroni, C.; Costanzo, C.; Palmieri, M.; Donadelli, M. UCP2 inhibition triggers ROSdependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. Biochim. Biophys. Acta, 2013, 1833 (3), 672-679.
134. Qian, W. B.; Liu, J. Q.; Jin, J.; Ni, W. M.; Xu, W. L. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk. Res., 2007, 31 (3), 329-339.
135. Kanzawa, T.; Kondo, Y.; Ito, H.; Kondo, S.; Germano, I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res., 2003, 63 (9), 2103-2108.
136. Kanzawa, T.; Zhang, L.; Xiao, L.; Germano, I. M.; Kondo, Y.; Kondo, S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene, 2005, 24 (6), 980-991.
137. Kim, Y.; Kim, Y. S.; Kim, D. E.; Lee, J. S.; Song, J. H.; Kim, H. G.; Cho, D. H.; Jeong, S. Y.; Jin, D. H.; Jang, S. J.; Seol, H. S.; Suh, Y. A.; Lee, S. J.; Kim, C. S.; Koh, J. Y.; Hwang, J. J. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy, 2013, 9 (12), 2126-2139.
138. Bonnet, S.; Archer, S. L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C. T.; Lopaschuk, G. D.; Puttagunta, L.; Bonnet, S.; Harry, G.; Hashimoto, K.; Porter, C. J.; Andrade, M. A.; Thebaud, B.; Michelakis, E. D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 2007, 11 (1), 37-51.
139. Lin, G.; Hill, D. K.; Andrejeva, G.; Boult, J. K. R.; Troy, H.; Fong, A. C. L. F. W. T.; Orton, M. R.; Panek, R.; Parkes, H. G.; Jafar, M.; Koh, D. M.; Robinson, S. P.; Judson, I. R.; Griffiths, J. R.; Leach, M. O.; Eykyn, T. R.; Chung, Y. L. Dichloroacetate induces autophagy in colorectal cancer cells and tumours. Br. J. Cancer, 2014, 111 (2), 375-385.
140. Liu, Y.; Zhao, L.; Ju, Y.; Li, W.; Zhang, M.; Jiao, Y.; Zhang, J.; Wang, S.; Wang, Y.; Zhao, M.; Zhang, B.; Zhao, Y. A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF). Cell Death Dis., 2014, 5, e1361.
141. Qi, M.; Fan, S.; Yao, G.; Li, Z.; Zhou, H.; Tashiro, S.; Onodera, S.; Xia, M.; Ikejima, T. Pseudolaric acid B-induced autophagy contributes to senescence via enhancement of ROS generation and mitochondrial dysfunction in murine fibrosarcoma L929 cells. J. Pharmacol. Sci., 2013, 121 (3), 200-211.
142. Wang, Y.; Wang, J. W.; Xiao, X.; Shan, Y.; Xue, B.; Jiang, G.; He, Q.; Chen, J.; Xu, H. G.; Zhao, R. X.; Werle, K. D.; Cui, R.; Liang, J.; Li, Y. L.; Xu, Z. X. Piperlongumine induces autophagy by targeting p38 signaling. Cell Death Dis., 2013, 4, e824.
143. D'Anneo, A.; Carlisi, D.; Lauricella, M.; Puleio, R.; Martinez, R.; Di Bella, S.; Di Marco, P.; Emanuele, S.; Di Fiore, R.; Guercio, A.; Vento, R.; Tesoriere, G. Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer. Cell Death Dis., 2013, 4, e891.
144. Duan, W. J.; Li, Q. S.; Xia, M. Y.; Tashiro, S.; Onodera, S.; Ikejima, T. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways. Biol. Pharm. Bull., 2011, 34 (1), 47-53.
145. Duan, W. J.; Li, Q. S.; Xia, M. Y.; Tashiro, S.; Onodera, S.; Ikejima, T. Silibinin activated ROS-p38-NF-kappaB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells. J. Asian Nat. Prod. Res., 2011, 13 (1), 27-35.
146. Liu, B.; Cheng, Y.; Bian, H. J.; Bao, J. K. Molecular mechanisms of Polygonatum cyrtonema lectin-induced apoptosis and autophagy in cancer cells. Autophagy, 2009, 5 (2), 253-255.
147. He, L.; Liao, S. Y.; Tan, C. P.; Lu, Y. Y.; Xu, C. X.; Ji, L. N.; Mao, Z. W. Cyclometalated iridium(III)-beta-carboline complexes as potent autophagy-inducing agents. Chem. Commun. (Camb.), 2014, 50 (42), 5611-5614.
148. Panzarini, E.; Dini, L. Nanomaterial-Induced Autophagy: A New Reversal MDR Tool in Cancer Therapy? Mol. Pharm., 2014, 11 (8), 2527-2538.
149. Yu, Y. B.; Duan, J. C.; Yu, Y.; Li, Y.; Liu, X. M.; Zhou, X. Q.; Ho, K. F.; Tian, L. W.; Sun, Z. W. Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species. J. Hazard. Mater., 2014, 270, 176-186.
150. Fiorito, S.; Flahaut, E.; Rapino, S.; Paolucci, F.; Andreola, F.; Moroni, N.; Pittaluga, E.; Zonfrillo, M.; Valenti, G.; Mastrofrancesco, A.; Groppi, F.; Sabbioni, E.; Bakalis, E.; Zerbetto, F.; Serafino, A. Redox active Double Wall Carbon Nanotubes show intrinsic anti-proliferative effects and modulate autophagy in cancer cells. Carbon, 2014, 78, 589-600.
151. Maiuri, M. C.; Criollo, A.; Tasdemir, E.; Vicencio, J. M.; Tajeddine, N.; Hickman, J. A.; Geneste, O.; Kroemer, G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy, 2007, 3 (4), 374-376.
152. Lian, J.; Wu, X.; He, F.; Karnak, D.; Tang, W.; Meng, Y.; Xiang, D.; Ji, M.; Lawrence, T. S.; Xu, L. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ., 2011, 18 (1), 60-71.
153. Malik, S. A.; Orhon, I.; Morselli, E.; Criollo, A.; Shen, S.; Marino, G.; BenYounes, A.; Benit, P.; Rustin, P.; Maiuri, M. C.; Kroemer, G. BH3 mimetics activate multiple pro-autophagic pathways. Oncogene, 2011, 30 (37), 3918-3929.
154. Schwartz-Roberts, J. L.; Shajahan, A. N.; Cook, K. L.; Warri, A.; Abu-Asab, M.; Clarke, R. GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D-and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells. Mol. Cancer Ther., 2013, 12 (4), 448-459.
155. Pan, J. X.; Cheng, C. O.; Verstovsek, S.; Chen, Q.; Jin, Y. L.; Cao, Q. The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells. Cancer Lett., 2010, 293 (2), 167-174.
156. Kessel, D.; Reiners, J. J., Jr. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett., 2007, 249 (2), 294-299.
157. Wang, J. L.; Liu, D. X.; Zhang, Z. J.; Shan, S. M.; Han, X. B.; Srinivasula, S. M.; Croce, C. M.; Alnemri, E. S.; Huang, Z. W. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl. Acad. Sci. U. S. A., 2000, 97 (13), 7124-7129.
158. Nyhan, M. J.; O'Donovan, T. R.; Elzinga, B.; Crowley, L. C.; O'Sullivan, G. C.; McKenna, S. L. The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells. Br. J. Cancer, 2012, 106 (4), 711-718.
159. Zhong, J. T.; Xu, Y.; Yi, H. W.; Su, J.; Yu, H. M.; Xiang, X. Y.; Li, X. N.; Zhang, Z. C.; Sun, L. K. The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett., 2012, 323 (2), 180-187.
160. Lu, H.; Lin, C.; Zheng, Z.; Li, S.; Guo, S.; Zhang, X.; Fu, M.; Liang, X.; Wu, M. Angiogenesis inhibitor Z24 induces endothelial cell apoptosis and suppresses tumor growth and metastasis. J. Pharmacol. Sci., 2005, 97 (4), 533-540.
161. Tian, S.; Lin, J.; Jun Zhou, J.; Wang, X.; Li, Y.; Ren, X.; Yu, W.; Zhong, W.; Xiao, J.; Sheng, F.; Chen, Y.; Jin, C.; Li, S.; Zheng, Z.; Xia, B. Beclin 1-independent autophagy induced by a Bcl-XL/Bcl-2 targeting compound, Z18. Autophagy, 2010, 6 (8), 1032-1041.
162. Lin, J.; Zheng, Z. B.; Li, Y. J.; Yu, W. Y.; Zhong, W.; Tian, S. H.; Zhao, F.; Ren, X. B.; Xiao, J. H.; Wang, N.; Liu, S. Y.; Wang, L. L.; Sheng, F. G.; Chen, Y. Y.; Jin, C. W.; Li, S.; Xia, B. A novel Bcl-X-L inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy, 2009, 5 (3), 314-320.
163. Ding, W. X.; Ni, H. M.; Gao, W. T.; Chen, X. Y.; Kang, J. H.; Stolz, D. B.; Liu, J. S.; Yin, X. M. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Mol. Cancer Ther., 2009, 8 (7), 2036-2045.
164. Zhu, K.; Dunner, K.; McConkey, D. J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene, 2010, 29 (3), 451-462.
165. Laussmann, M. A.; Passante, E.; Dussmann, H.; Rauen, J. A.; Wurstle, M. L.; Delgado, M. E.; Devocelle, M.; Prehn, J. H. M.; Rehm, M. Proteasome inhibition can induce an autophagydependent apical activation of caspase-8. Cell Death Differ., 2011, 18 (10), 1584-1597.
166. Cho, K. H.; Park, J. H.; Kwon, K. B.; Lee, Y. R.; So, H. S.; Lee, K. K.; Lee, S. Y.; Moon, S. R.; Yang, S. H. Autophagy induction by low-dose cisplatin: the role of p53 in autophagy. Oncol. Rep., 2014, 31 (1), 248-254.
167. Bordin, D. L.; Lima, M.; Lenz, G.; Saffi, J.; Meira, L. B.; Mesange, P.; Soares, D. G.; Larsen, A. K.; Escargueil, A. E.; Henriques, J. A. P. DNA alkylation damage and autophagy induction. Mutation Research-Reviews In Mutation Research, 2013, 753 (2), 91-99.
168. Liu, M.; Ma, S.; Liu, M.; Hou, Y.; Liang, B.; Su, X.; Liu, X. Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis. Oncol Lett, 2014, 7 (6), 1903-1910.
169. Shi, Y.; Tang, B.; Yu, P. W.; Tang, B.; Hao, Y. X.; Lei, X.; Luo, H. X.; Zeng, D. Z. Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells. PLoS ONE, 2012, 7 (11), e51076.
170. Guyton, K. Z.; Kensler, T. W.; Posner, G. H. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr. Rev., 2003, 61 (7), 227-238.
171. Johnson, C. S.; Hershberger, P. A.; Bernardi, R. J.; McGuire, T. F.; Trump, D. L. Vitamin D receptor: a potential target for intervention. Urology, 2002, 60 (3 Suppl 1), 123-130; discussion 130-121.
172. Wang, J.; Lian, H.; Zhao, Y.; Kauss, M. A.; Spindel, S. Vitamin D3 induces autophagy of human myeloid leukemia cells. J. Biol. Chem., 2008, 283 (37), 25596-25605.
173. Chiao, M. T.; Cheng, W. Y.; Yang, Y. C.; Shen, C. C.; Ko, J. L. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy, 2013, 9 (10), 1509-1526.
174. Carew, J. S.; Medina, E. C.; Esquivel, J. A., 2nd; Mahalingam, D.; Swords, R.; Kelly, K.; Zhang, H.; Huang, P.; Mita, A. C.; Mita, M. M.; Giles, F. J.; Nawrocki, S. T. Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J. Cell. Mol. Med., 2010, 14 (10), 2448-2459.
175. Park, J. H.; Lee, Y. R.; So, H. S.; Lee, K. K.; Lee, S. Y.; Moon, S. R.; Jo, H. J.; Lee, S.; Jeong, K.; Kwon, K. B.; Yang, S. H. The role of autophagy induced by pemetrexed in lung adenocarcinoma cells. Oncol. Rep., 2014, 31 (5), 2365-2370.
176. Jensen, E. V.; Jordan, V. C. The estrogen receptor: A model for molecular medicine. Clin. Cancer Res., 2003, 9 (6), 1980-1989.
177. Cho, K. S.; Yoon, Y. H.; Choi, J. A.; Lee, S. J.; Koh, J. Y. Induction of Autophagy and Cell Death by Tamoxifen in Cultured Retinal Pigment Epithelial and Photoreceptor Cells. Invest. Ophthalmol. Vis. Sci., 2012, 53 (9), 5344-5353.
178. Son, M. J.; Lee, S. B.; Byun, Y. J.; Lee, H. O.; Kim, H. S.; Kwon, O. J.; Jeong, S. W. Sodium nitroprusside induces autophagic cell death in glutathione-depleted osteoblasts. J. Biochem. Mol. Toxicol., 2010, 24 (5), 313-322.
179. DeCensi, A.; Puntoni, M.; Goodwin, P.; Cazzaniga, M.; Gennari, A.; Bonanni, B.; Gandini, S. Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prev. Res. (Phila. Pa.), 2010, 3 (11), 1451-1461.
180. Feng, Y.; Ke, C.; Tang, Q.; Dong, H.; Zheng, X.; Lin, W.; Ke, J.; Huang, J.; Jeung, S. C. J.; Zhang, H. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis., 2014, 5.
181. Cheong, H.; Lindsten, T.; Wu, J. M.; Lu, C.; Thompson, C. B. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc. Natl. Acad. Sci. U. S. A., 2011, 108 (27), 11121-11126.
182. Eng, C. H.; Yu, K.; Lucas, J.; White, E.; Abraham, R. T. Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy. Sci. Signal., 2010, 3 (119).
183. Cheong, H.; Lindsten, T.; Thompson, C. B. Autophagy and ammonia. Autophagy, 2012, 8 (1), 122-123.
184. Hu, Y. Z.; Xia, Q.; Shihao, S. G.; Liu, X. W.; Hu, Y. Z.; Sheng, R. Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1, 4-Di-N-oxide Derivatives as Hypoxic Selective Antitumor Agents. Molecules, 2012, 17 (8), 9683-9696.
185. Liu, X. W.; Cai, T. Y.; Zhu, H.; Cao, J.; Su, Y.; Hu, Y. Z.; He, Q. J.; Yang, B. Q6, a novel hypoxia-targeted drug, regulates hypoxiainducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma. Autophagy, 2014, 10 (1), 111-122.
186. Wan, G.; Xie, W. D.; Liu, Z. Y.; Xu, W.; Lao, Y. Z.; Huang, N. N.; Cui, K.; Liao, M. J.; He, J.; Jiang, Y. Y.; Yang, B. B.; Xu, H. X.; Xu, N. H.; Zhang, Y. U. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway. Autophagy, 2014, 10 (1), 70-79.
187. Wu, H.; Wang, F.; Hu, S.; Yin, C.; Li, X.; Zhao, S.; Wang, J.; Yan, X. MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts. Cell. Signal., 2012, 24 (11), 2179-2186.
188. Zou, Z. Y.; Wu, L. P.; Ding, H. Y.; Wang, Y.; Zhang, Y. Q.; Chen, X. J.; Chen, X.; Zhang, C. Y.; Zhang, Q. P.; Zen, K. MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy. J. Biol. Chem., 2012, 287 (6), 4148-4156.
189. Zhu, H.; Wu, H.; Liu, X. P.; Li, B. A.; Chen, Y.; Ren, X. C.; Liu, C. G.; Yang, J. M. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy, 2009, 5 (6), 816-823.
190. Korkmaz, G.; le Sage, C.; Tekirdag, K. A.; Agami, R.; Gozuacik, D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy, 2012, 8 (2), 165-176.
191. Frankel, L. B.; Lund, A. H. MicroRNA regulation of autophagy. Carcinogenesis, 2012, 33 (11), 2018-2025.
192. Fang, Y.; Xue, J. L.; Shen, Q.; Chen, J.; Tian, L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology, 2012, 55 (6), 1852-1862.
193. Zhang, Z. C.; Song, T.; Zhang, T. T.; Gao, J.; Wu, G. Y.; An, L. J.; Du, G. H. A novel BH3 mimetic S1 potently induces Bax/Bakdependent apoptosis by targeting both Bcl-2 and Mcl-1. Int. J. Cancer, 2011, 128 (7), 1724-1735.
194. Takezawa, J.; Ishimi, Y.; Yamada, K. Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells. Cancer Sci., 2008, 99 (5), 863-871.
195. Sun, H.; Wang, Z.; Yakisich, J. S. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer Agents Med. Chem., 2013, 13 (7), 1048-1056.
196. Choi, Y. J.; Park, Y. J.; Park, J. Y.; Jeong, H. O.; Kim, D. H.; Ha, Y. M.; Kim, J. M.; Song, Y. M.; Heo, H. S.; Yu, B. P.; Chun, P.; Moon, H. R.; Chung, H. Y. Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion. PLoS ONE, 2012, 7 (8).
197. Petiot, A.; Ogier-Denis, E.; Blommaart, E. F. C.; Meijer, A. J.; Codogno, P. Distinct classes of phosphatidylinositol 3 '-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem., 2000, 275 (2), 992-998.
198. Wu, Y. T.; Tan, H. L.; Shui, G. H.; Bauvy, C.; Huang, Q.; Wenk, M. R.; Ong, C. N.; Codogno, P.; Shen, H. M. Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase. J. Biol. Chem., 2010, 285 (14), 10850-10861.
199. Li, J.; Ni, M.; Lee, B.; Barron, E.; Hinton, D. R.; Lee, A. S. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ., 2008, 15 (9), 1460-1471.
200. Selvakumaran, M.; Amaravadi, R. K.; Vasilevskaya, I. A.; O'Dwyer, P. J. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin. Cancer Res., 2013, 19 (11), 2995-3007.
201. Tran, A. T.; Ramalinga, M.; Kedir, H.; Clarke, R.; Kumar, D. Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells. Eur. J. Nutr., 2014.
202. Coker-Gurkan, A.; Arisan, E. D.; Obakan, P.; Guvenir, E.; Unsal, N. P. Inhibition of autophagy by 3-MA potentiates purvalanolinduced apoptosis in Bax deficient HCT 116 colon cancer cells. Exp. Cell Res., 2014.
203. Liu, J. L.; Xia, H. G.; Kim, M.; Xu, L. H.; Li, Y.; Zhang, L. H.; Cai, Y.; Norberg, H. V.; Zhang, T.; Furuya, T.; Jin, M. Z.; Zhu, Z. M.; Wang, H. C.; Yu, J.; Li, Y. X.; Hao, Y.; Choi, A.; Ke, H. M.; Ma, D. W.; Yuan, J. Y. Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13. Cell, 2011, 147 (1), 223-234.
204. Shao, S.; Li, S.; Qin, Y. W.; Wang, X. R.; Yang, Y. N.; Bai, H. T.; Zhou, L. L.; Zhao, C. X.; Wang, C. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Int. J. Oncol., 2014, 44 (5), 1661-1668.
205. Wong, S. S. C.; Woo, P. T. L. Stimulation by Glucagon And Adenosine-3', 5'-Cyclic Monophosphate Of Protein-Degradation In Reuber-H35 Hepatoma Monolayers. Int. J. Biochem., 1987, 19 (5), 443-447.
206. McFarlane, S.; Aitken, J.; Sutherland, J. S.; Nicholl, M. J.; Preston, V. G.; Preston, C. M. Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J. Virol., 2011, 85 (9), 4212-4221.
207. Watanabe-Asano, T.; Kuma, A.; Mizushima, N. Cycloheximide inhibits starvation-induced autophagy through mTORC1 activation. Biochem. Biophys. Res. Commun., 2014, 445 (2), 334-339.
208. El-Khoury, V.; Moussay, E.; Janji, B.; Palissot, V.; Aouali, N.; Brons, N. H. C.; Van Moer, K.; Pierson, S.; Van Dyck, E.; Berchem, G. The Histone Deacetylase Inhibitor MGCD0103 Induces Apoptosis in B-Cell Chronic Lymphocytic Leukemia Cells through a Mitochondria-Mediated Caspase Activation Cascade. Mol. Cancer Ther., 2010, 9 (5), 1349-1360.
209. El-Khoury, V.; Pierson, S.; Szwarcbart, E.; Brons, N. H.; Roland, O.; Cherrier-De Wilde, S.; Plawny, L.; Van Dyck, E.; Berchem, G. Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia. Leukemia, 2014, 28 (8), 1636-1646.
210. Chaachouay, H.; Ohneseit, P.; Toulany, M.; Kehlbach, R.; Multhoff, G.; Rodemann, H. P. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother. Oncol., 2011, 99 (3), 287-292.
211. Sun, Q.; Liu, T.; Yuan, Y.; Guo, Z.; Xie, G.; Du, S.; Lin, X.; Xu, Z.; Liu, M.; Wang, W.; Yuan, Q.; Chen, L. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int. J. Cancer, 2014.
212. Shukla, S.; Patric, I. R.; Patil, V.; Shwetha, S. D.; Hegde, A. S.; Chandramouli, B. A.; Arivazhagan, A.; Santosh, V.; Somasundaram, K. Methylation Silencing of ULK2, an Autophagy Gene, Is Essential for Astrocyte Transformation and Tumor Growth. J. Biol. Chem., 2014, 289 (32), 22306-22318.
213. Blommaart, E. F.; Krause, U.; Schellens, J. P.; Vreeling-Sindelarova, H.; Meijer, A. J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem., 1997, 243 (1-2), 240-246.
214. Kochl, R.; Hu, X. W.; Chan, E. Y. W.; Tooze, S. A. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic, 2006, 7 (2), 129-145.
215. Homewood, C. A.; Warhurst, D. C.; Peters, W.; Baggaley, V. C. Lysosomes, pH and the anti-malarial action of chloroquine. Nature, 1972, 235 (5332), 50-52.
216. Maes, H.; Kuchnio, A.; Peric, A.; Moens, S.; Nys, K.; De Bock, K.; Quaegebeur, A.; Schoors, S.; Georgiadou, M.; Wouters, J.; Vinckier, S.; Vankelecom, H.; Garmyn, M.; Vion, A. C.; Radtke, F.; Boulanger, C.; Gerhardt, H.; Dejana, E.; Dewerchin, M.; Ghesquiere, B.; Annaert, W.; Agostinis, P.; Carmeliet, P. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell, 2014, 26 (2), 190-206.
217. Firat, E.; Weyerbrock, A.; Gaedicke, S.; Grosu, A. L.; Niedermann, G. Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS ONE, 2012, 7 (10), e47357.
218. Kimura, T.; Takabatake, Y.; Takahashi, A.; Isaka, Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res., 2013, 73 (1), 3-7.
219. Qiao, S.; Tao, S.; Rojo de la Vega, M.; Park, S. L.; Vonderfecht, A. A.; Jacobs, S. L.; Zhang, D. D.; Wondrak, G. T. The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation-and chemotherapy-induced cell death. Autophagy, 2013, 9 (12), 2087-2102.
220. Yamamoto, A.; Tagawa, Y.; Yoshimori, T.; Moriyama, Y.; Masaki, R.; Tashiro, Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct., 1998, 23 (1), 33-42.
221. Xie, Z.; Xie, Y.; Xu, Y.; Zhou, H.; Xu, W.; Dong, Q. Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63 osteosarcoma cells. Mol. Med. Rep., 2014, 10 (2), 1103-1107.
222. Kallifatidis, G.; Hoepfner, D.; Jaeg, T.; Guzman, E. A.; Wright, A. E. The Marine Natural Product Manzamine A Targets Vacuolar ATPases and Inhibits Autophagy in Pancreatic Cancer Cells. Mar. Drugs, 2013, 11, 3500-3516.
223. Marine Drugs, 2014, 12 (4), 2305-2307.
224. Muller, S.; Dennemarker, J.; Reinheckel, T. Specific functions of lysosomal proteases in endocytic and autophagic pathways. Biochim. Et. Biophys. Acta-Proteins Proteom., 2012, 1824 (1), 34-43.
225. Wang, Z.; Zhang, J.; Wang, Y.; Xing, R.; Yi, C.; Zhu, H.; Chen, X.; Guo, J.; Guo, W.; Li, W.; Wu, L.; Lu, Y.; Liu, S. Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis, 2013, 34 (1), 128-138.
226. Juhasz, G. Interpretation of bafilomycin, pH neutralizing or protease inhibitor treatments in autophagic flux experiments: novel considerations. Autophagy, 2012, 8 (12), 1875-1876.
227. Ding, W. X.; Ni, H. M.; Gao, W.; Hou, Y. F.; Melan, M. A.; Chen, X.; Stolz, D. B.; Shao, Z. M.; Yin, X. M. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem., 2007, 282 (7), 4702-4710.